Inhibition of epidermal-growth-factor-receptor-dependent signalling by tyrphostins A25 and AG1478 blocks growth and induces apoptosis in colorectal tumor cells in vitro

Journal of Cancer Research and Clinical Oncology

Volumn 125, Issue 7, 1999, Pages 379-388

  Partik, Gerda ^a   Hochegger, Karin ^a   Schörkhuber, Michaela ^a   Marian, Brigitte ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Apoptosis; Colon cancer; EGF receptor signalling; Tyrphostin

Indexed keywords

3,4 DIHYDROXYBENZYLIDENE MALONONITRILE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZINOLINE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; A 25; ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR; TYRPHOSTIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL COUNT; CELL STRUCTURE; COLORECTAL CANCER; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TIME;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; COLORECTAL NEOPLASMS; DNA, NEOPLASM; ENZYME INHIBITORS; FLOW CYTOMETRY; HUMANS; MEMBRANE PROTEINS; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; TYRPHOSTINS;

EID: 0033037775     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320050290     Document Type: Article

References (41)

1. Arai T, Kino I (1995) Role of apoptosis in modulation of the growth of human colorectal tubular and villous adenomas. J Pathol 176:37-44
2. Bauknecht T, Kohler M, Janz I, Pfleiderer A (1989) The occurrence of epidermal growth factor receptors and the characterization of EGF-like factors in human ovarian, endometrial, cervical and breast cancer. EGF receptors and factors in gynecological carcinomas. J Cancer Res Clin Oncol 115:193-199
3. Bedi A, Pasricha PJ, Akhtar AJ, Barber JP, Bedi GC, Giardiello FM, Zehnbauer BA, Hamilton SR, Jones RJ (1995) Inhibition of apoptosis during development of colorectal cancer. Cancer Res 55:1811-1816
4. Coffey RJ, Shipley GD, Moses HL (1986) Production of transforming growth factors by human colon cancer cell lines. Cancer Res 46:1164-1169
5. Coffey RJ Jr, Graves Deal R, Dempsey PJ, Whitehead RH, Pittelkow MR (1992) Differential regulation of transforming growth factor alpha autoinduction in a nontransformed and transformed epithelial cell. Cell Growth Differ 3:347-354
6. Dernyck R (1992) The physiology of transforming growth factor alpha. In: Vande Woude GF, Klein G (eds) Adv Cancer Res, vol 58, Acad. Press, San Diego, pp 27-52
7. Di Marco E, Pierce JH, Fleming TP, Kraus MH, Molloy CJ, Aaronson SA, Di Fiore PP (1989) Autocrine interaction between TGF alpha and the EGF-receptor: quantitative requirements for induction of the malignant phenotype. Oncogene 4:831-838
8. Faaland CA, Mermelstein FH, Hayoshi J, Laskin JD (1991) Rapid uptake of tyrphostin into A431 human epidermoid cells is followed by delayed inhibition of epidermal growth factor (EGF)-stimulated EGF receptor tyrosine kinase activity. Mol Cell Biol 11:2697-2703
9. Hafez MM, Infante D, Winawer S, Friedman E (1990) Transforming growth factor beta 1 acts as an autocrine-negative growth regulator in colon enterocytic differentiation but not in goblet cell maturation. Cell Growth Differ 1:617-626
10. Hague A, Manning AM, Hanlon KA, Huschtscha LI, Hart D, Paraskeva C (1993) Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: implications for the possible role of dietary fibre in the prevention of large-bowel cancer. Int J Cancer 55:498-505
11. Haim W, LeRoith D (1996) The role of the insulin-like growth factor system in human cancer. In: Vande Woude GF, Klein G (eds) Adv Cancer Res, Vol. 68. Acad. Press, San Diego, pp 183-223
12. Karnes WE jr, Walsh JH, Wu SV, Kim RS, Martin MG, Wong HC, Mendelsohn J, Park J-G, Cuttitta F (1992) Autonomous proliferation of colon carcinoma cells that co-express transforming growth factor alpha and its receptor: variable effect of receptor-blocking antibody. Gastroenterology 102:474-485
13. Karnes WE jr, Weller SG, Adjei PN, Kottke TJ, Glenn KS, Gores GJ, Kaufmann SH (1998) Inhibition of epidermal growth factor receptor kinase induces protease-dependent apoptosis in human colon cancer cells. Gastroenterology 114:930-939
14. Krajewski S, Krajewska M, Shabaik A, Miyashita T, Wang HG, Reed JC (1994) Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am J Pathol 145:1323-1336
15. Krajewski S, Bodrug S, Krajewska M, Shabaik A, Gascoyne R, Berean K, Reed JC (1995) Immunohistochemical analysis of Mcl-1 protein in human tissues. Differential regulation of Mcl-1 and Bcl-2 protein production suggests a unique role for Mcl-1 in control of programmed cell death in vivo. Am J Pathol 146:1309-1319
16. Krajewski S, Krajewska M, Reed JC (1996) Immunohistochemical analysis of in vivo patterns of Bak expression, a proapoptotic member of the Bcl-2 protein family. Cancer Res 56:2849-2855
17. Levitzki A, Gazit A, Osherov N, Posner I, Gilon C (1991) Inhibition of proteintyrosine kinases by tyrphostins. Methods Enzymol 201:347-361
18. Levitzki A, Gazit A (1995) Tyrosine kinase inhibition: an approach to drug development. Science 267:1782-1788
19. Marian B, Winawer S, Friedman E (1989) Tyrosine phosphorylation of a Mr 63,000 protein induced by an endogenous mitogen in human colon carcinoma cells, but not in normal colonocytes. Cancer Res 49:4231-4236
20. Markowitz SD, Molkentin K, Gerbic C, Jackson J, Stellato T, Willson JK (1990) Growth stimulation by coexpression of transforming growth factor-alpha and epidermal growth factor-receptor in normal and adenomatous human colon epithelium. J Clin Invest 86:356-362
21. Masui H, Moroyama T, Mendelsohn J (1986) Mechanism of antitumor activity in mice for anti-epidermal growth factor receptor monoclonal antibodies with different isotypes. Cancer Res 46:5592-5598
22. Mendelsohn J (1992) Epidermal growth factor receptor as a target for therapy with antireceptor monoclonal antibodies. J Natl Cancer Inst Monogr 13:125-131
23. Moss SF, Agarwal B, Arber N, Guan RJ, Krajewska M, Krajewski S, Reed JC, Holt PR (1996) Increased intestinal Bak expression results in apoptosis. Biochem Biophys Res Commun 223:199-203
24. Moyer JD, Barbacci EG, Iwata KK, Arnold L, Boman B, Cunningham A, DiOrio C, Doty J, Morin MJ, Moyer MP, Neveu M, Pollack VA, Pustilnik LR, Reynolds MM, Sloan D, Theleman A, Miller P (1997) Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase. Cancer Research 57 (21):4838-4848
25. Osherov N, Levitzki A (1994) Epidermal-growth-factor-dependent activation of the src-family kinases. Eur J Biochem 225:1047-1053
26. Osherov N, Gazit A, Gilon C, Levitzki A (1993) Selective inhibition of the epidermal growth factor and HER2/neu receptors by tyrphostins. J Biol Chem 268:11134-11142
27. Partik G, KahlRainer P, Sedivy R, Ellinger A, Bursch W, Marian B (1998) Apoptosis in human colorectal tumours: ultrastructure and quantitative studies on tissue localization and association with bak expression. Virchows Archiv an International Journal Of Pathology 432 (5):415-426
28. Pekonen F, Partanen S, Rutanen EM (1989) Binding of epidermal growth factor and insulin-like growth-factor I in renal carcinoma and adjacent normal kidney tissue. Int J Cancer 43:1029-1033
29. Ramdas L, McMurray JS, Budde RJ (1994) The degree of inhibition of protein tyrosine kinase activity by tyrphostin 23 and 25 is related to their instability. Cancer Res 54:867-869
30. Ramdas L, Obeyesekere NU, McMurray JS, Gallick GE, Seifert WE Jr, Budde RJ (1995) A tyrphostin-derived inhibitor of protein tyrosine kinases: isolation and characterization. Arch Biochem Biophys 323:237-242
31. Resnicoff M, Abraham D, Yutanawiboonchai W, Rotman HL, Kajstura J, Rubin R, Zoltick P, Baserga R (1995) The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo. Cancer Res 55:2463-2469
32. Sauma S, Yan Z, Ohno S, Friedman E (1996) Protein kinase C beta 1 and protein kinase C beta 2 activate p57 mitogen-activated protein kinase and block differentiation in colon carcinoma cells. Cell Growth Differ 7:587-594
33. Schlessinger J (1988) Signal transduction by allosteric receptor oligomerization. Trends Biochem Sci 13:443-447
34. Schörkhuber M, Karner-Hanusch J, Sedivy R, Ellinger A, Armbruster C, Marian B (1988) Survival of normal colonic epithelial cells is prolonged by coculture with rat embryo colonic fibroblasts. Cell Biol & Toxicol 14:211-233
35. Sporn MB, Todaro GJ (1980) Autocrine secretion and malignant transformation of cells. N Engl J Med 303:878-880
36. Tatebe S, Ishida M, Kasagi N, Tsujitani S, Kaibara N, Ito H (1996) Apoptosis occurs more frequently in metastatic foci than in primary lesions of human colorectal carcinomas: analysis by terminal-deoxynucleotidyl-transferase-mediated dUTP-biotin nick end labeling. Int J Cancer 65:173-177
37. Todd R, Donoff BR, Gertz R, Chang AL, Chow P, Matossian K, McBride J, Chiang T, Gallagher GT, Wong DT (1989) TGF-alpha and EGF-receptor mRNAs in human oral cancers. Carcinogenesis 10:1553-1556
38. Willson JK, Bittner GN (1988) In vitro models of human colonic adenomatous polyps. Prog Clin Biol Res 279:347-356
39. Willson JK, Bittner GN, Oberley TD, Meisner LF, Weese JL (1987) Cell culture of human colon adenomas and carcinomas. Cancer Res 47:2704-2713
40. Wu X, Fan Z, Masui H, Rosen N, Mendelsohn J (1995) Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin. J Clin Invest 95:1897-1905
41. Yoneda T, Alsina MM, Watatani K, Bellot F, Schlessinger J, Mundy GR (1991) Dependence of a human squamous carcinoma and associated paraneoplastic syndromes on the epidermal growth factor receptor pathway in nude mice. Cancer Res 51:2438-2443